Concepedia

Shiwen Huo

SH

2

Publications

59

Citations

2

H-Index

2022

Active since

Affiliations

Jiangsu Hengrui Medicine (China)(Current)

First Hospital of China Medical University

China Medical University

Anshan Hospital

Shiwen Huo is an author at Jiangsu Hengrui Medicine (China) specializing in clinical trials, molecular oncology, and cancer therapeutics.

Top concepts

Publications per year

2022–2024

2

Publications

2

A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer

Nan Niu, Fang Qiu, Qianshi Xu et al. · Nature Communications · 2022 · 48 citations · Full text

, , +15

A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer

Shiwen Huo, Jinqi Xue, Shuo Wang et al. · MedComm · 2024 · 11 citations · Full text

Rows per page

1–2 of 2